Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutrisorb is a specialized biotechnology and nutraceutical company focused on the development of high-potency liquid nutritional formulations. The company utilizes a proprietary micellization process to enhance the bioavailability and absorption of essential vitamins and minerals, particularly for individuals with compromised digestive systems or malabsorption issues. Their product portfolio includes a wide range of liquid-based supplements such as Vitamin D, Vitamin B12, and trace minerals designed for flexible dosing and rapid systemic uptake. Nutrisorb's technology is frequently integrated into clinical nutrition protocols to address specific dietary deficiencies where traditional tablet or capsule forms are ineffective.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutrisorb.